T1	CHEM 12 33	aceite de sacha inchi
#1	AnnotatorNotes T1	C2710473; Plukenetia volubilis Oil; Organic Chemical · Pharmacologic Substance
T2	CHEM 75 83	lipídico
#2	AnnotatorNotes T2	C0023779; Lipids; Organic Chemical
T3	DISO 101 121	hiperlipoproteinemia
#3	AnnotatorNotes T3	C0020476; Hyperlipoproteinemias; Disease or Syndrome
T4	DISO 220 239	efectos secundarios
#4	AnnotatorNotes T4	C0559546; Adverse reactions; Pathologic Function | C0879626; Adverse effects; Pathologic Function
T5	CHEM 244 265	aceite de sacha inchi
#5	AnnotatorNotes T5	C2710473; Plukenetia volubilis Oil; Organic Chemical · Pharmacologic Substance
T6	CHEM 304 312	lipídico
#6	AnnotatorNotes T6	C0023779; Lipids; Organic Chemical
T7	DISO 330 349	hipercolesterolemia
#7	AnnotatorNotes T7	C0020443; Hypercholesterolemia; Disease or Syndrome
T8	PROC 563 576	Se aleatorizó
#8	AnnotatorNotes T8	C0034656; Randomization; Research Activity
T9	PROC 433 471	valores sanguíneos de colesterol total
#9	AnnotatorNotes T9	C1445957; Serum total cholesterol measurement; Laboratory Procedure
T10	ANAT 441 451	sanguíneos
#10	AnnotatorNotes T10	C0005767; Blood; Body Substance
T11	CHEM 455 465	colesterol
#11	AnnotatorNotes T11	C0008377; cholesterol; Organic Chemical · Biologically Active Substance
T12	PROC 897 909	aleatorizado
#12	AnnotatorNotes T12	C0034656; Randomization; Research Activity
T13	PROC 993 1008	perfil lipídico
#13	AnnotatorNotes T13	C0523744; Lipids measurement; Laboratory Procedure
T14	PROC 503 510	glucosa
#14	AnnotatorNotes T14	C0337438; Glucose measurement; Laboratory Procedure
T15	PROC 512 542	ácidos grasos no esterificados
#15	AnnotatorNotes T15	C2698488; Nonesterified Fatty Acids Measurement; Laboratory Procedure
T16	PROC 544 548	AGNE
#16	AnnotatorNotes T16	C2698488; Nonesterified Fatty Acids Measurement; Laboratory Procedure
T17	CHEM 664 685	aceite de sacha inchi
#17	AnnotatorNotes T17	C2710473; Plukenetia volubilis Oil; Organic Chemical · Pharmacologic Substance
T18	CHEM 725 731	aceite
#18	AnnotatorNotes T18	C0028908; Oils; Organic Chemical
T19	PROC 774 776	CT
#19	AnnotatorNotes T19	C1445957; Serum total cholesterol measurement; Laboratory Procedure
T20	PROC 780 784	AGNE
#20	AnnotatorNotes T20	C2698488; Nonesterified Fatty Acids Measurement; Laboratory Procedure
T21	PROC 803 808	c-HDL
#21	AnnotatorNotes T21	C0392885; High density lipoprotein measurement; Laboratory Procedure
T22	CHEM 876 884	insulina
#22	AnnotatorNotes T22	C0021641; Insulin; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance | C3537244; Insulins; Pharmacologic Substance
T23	CHEM 931 952	aceite de sacha inchi
#23	AnnotatorNotes T23	C2710473; Plukenetia volubilis Oil; Organic Chemical · Pharmacologic Substance
T24	CHEM 1000 1008	lipídico
#24	AnnotatorNotes T24	C0023779; Lipids; Organic Chemical
T25	DISO 1026 1038	dislipidemia
#25	AnnotatorNotes T25	C0242339; Dyslipidemias; Disease or Syndrome
T26	PROC 1057 1094	evaluación de su eficacia y seguridad
#26	AnnotatorNotes T26	C0511730; Identify product efficacy and safety issues; Health Care Activity
T27	PROC 473 475	CT
#27	AnnotatorNotes T27	C1445957; Serum total cholesterol measurement; Laboratory Procedure
T28	PROC 478 481	HDL
#28	AnnotatorNotes T28	C0392885; High density lipoprotein measurement; Laboratory Procedure
T29	PROC 483 496	triglicéridos
#29	AnnotatorNotes T29	C0202236; Triglycerides measurement; Laboratory Procedure
T30	PROC 498 500	Tg
#30	AnnotatorNotes T30	C0202236; Triglycerides measurement; Laboratory Procedure
T31	PROC 552 560	insulina
#31	AnnotatorNotes T31	C0202098; Insulin measurement; Laboratory Procedure
T32	PROC 865 884	niveles de insulina
#32	AnnotatorNotes T32	C0202098; Insulin measurement; Laboratory Procedure
T33	PROC 1098 1128	ensayos clínicos aleatorizados
#33	AnnotatorNotes T33	C0206034; Clinical Trials, Randomized; Research Activity
T34	PROC 68 83	perfil lipídico
#34	AnnotatorNotes T34	C0523744; Lipids measurement; Laboratory Procedure
T35	PROC 141 177	trabajo experimental piloto, abierto
#35	AnnotatorNotes T35	C1709323; Open Label Study; Research Activity + C0031928; Pilot Projects; Research Activity + C0678323; experimentation; Research Activity
T36	PROC 297 312	perfil lipídico
#36	AnnotatorNotes T36	C0523744; Lipids measurement; Laboratory Procedure
T37	LIVB 87 96	pacientes
#37	AnnotatorNotes T37	C0030705; Patients; Patient or Disabled Group
T38	LIVB 316 325	pacientes
#38	AnnotatorNotes T38	C0030705; Patients; Patient or Disabled Group
T39	LIVB 378 387	pacientes
#39	AnnotatorNotes T39	C0030705; Patients; Patient or Disabled Group
T40	Age 388 403	de 35 a 75 años
T42	Dose 610 614	5 mL
T43	Dose 617 622	10 mL
T44	Form 630 640	suspensión
#40	AnnotatorNotes T44	C4724031; Suspension Dosage Form; Biomedical or Dental Material
T45	Duration 695 707	cuatro meses
T46	Dose 839 844	10 mL
T48	Dose 920 925	10 ml
T49	LIVB 1012 1021	pacientes
#41	AnnotatorNotes T49	C0030705; Patients; Patient or Disabled Group
T50	LIVB 35 55	plukenetia volúbilis
#42	AnnotatorNotes T50	C1640937; Plukenetia volubilis; Plant
T51	LIVB 267 287	Plukenetia volúbilis
#43	AnnotatorNotes T51	C1640937; Plukenetia volubilis; Plant
T41	Dose 653 660	2gr/5ml
T52	LIVB 22 33	sacha inchi
#44	AnnotatorNotes T52	C1640937; Plukenetia volubilis; Plant
T53	LIVB 254 265	sacha inchi
#45	AnnotatorNotes T53	C1640937; Plukenetia volubilis; Plant
T54	LIVB 674 685	sacha inchi
#46	AnnotatorNotes T54	C1640937; Plukenetia volubilis; Plant
T47	LIVB 941 952	sacha inchi
#47	AnnotatorNotes T47	C1640937; Plukenetia volubilis; Plant
T55	PHYS 713 720	ingesta
#48	AnnotatorNotes T55	C0232478; Ingestion; Biologic Function
T56	LIVB 583 596	participantes
#49	AnnotatorNotes T56	C4554048; Study Participant; Population Group
T57	Spec_cue 953 959	parece
T58	Observation 966 983	efectos benéficos
A1	Assertion T58 Speculated
#50	AnnotatorNotes T58	C4049461; Unexpected beneficial therapeutic response; Finding (?)
R1	Speculation Arg1:T57 Arg2:T58	
R2	Before Arg1:T23 Arg2:T58	
T59	Neg_cue 526 528	no
T60	Quantifier_or_Qualifier 529 542	esterificados
A2	Assertion T60 Negated
R3	Experiences Arg1:T37 Arg2:T3	
R4	Experiences Arg1:T37 Arg2:T34	
R5	Experiences Arg1:T37 Arg2:T1	
T61	Observation 195 201	efecto
#51	AnnotatorNotes T61	C1518681; Outcome of Therapy; Finding (?)
R6	Causes Arg1:T5 Arg2:T61	
R7	Causes Arg1:T5 Arg2:T4	
R8	Experiences Arg1:T38 Arg2:T61	
R9	Experiences Arg1:T38 Arg2:T4	
R10	Experiences Arg1:T38 Arg2:T5	
R11	Experiences Arg1:T38 Arg2:T36	
R12	Experiences Arg1:T38 Arg2:T7	
R17	Has_Age Arg1:T39 Arg2:T40	
R18	Location_of Arg1:T10 Arg2:T9	
R19	Negation Arg1:T59 Arg2:T60	
R20	Has_Quantifier_or_Qualifier Arg1:T15 Arg2:T60	
R21	Experiences Arg1:T39 Arg2:T61	
R22	Experiences Arg1:T39 Arg2:T4	
R23	Experiences Arg1:T39 Arg2:T5	
R24	Experiences Arg1:T39 Arg2:T36	
R25	Experiences Arg1:T39 Arg2:T7	
R26	Has_Age Arg1:T38 Arg2:T40	
R27	Experiences Arg1:T39 Arg2:T9	
R28	Experiences Arg1:T39 Arg2:T27	
R29	Experiences Arg1:T39 Arg2:T28	
R30	Experiences Arg1:T39 Arg2:T29	
R31	Experiences Arg1:T39 Arg2:T30	
R32	Experiences Arg1:T39 Arg2:T14	
R33	Experiences Arg1:T39 Arg2:T15	
R34	Experiences Arg1:T39 Arg2:T16	
R35	Experiences Arg1:T39 Arg2:T31	
R36	Experiences Arg1:T38 Arg2:T9	
R37	Experiences Arg1:T38 Arg2:T27	
R38	Experiences Arg1:T38 Arg2:T28	
R39	Experiences Arg1:T38 Arg2:T29	
R40	Experiences Arg1:T38 Arg2:T30	
R41	Experiences Arg1:T38 Arg2:T14	
R42	Experiences Arg1:T38 Arg2:T15	
R43	Experiences Arg1:T38 Arg2:T16	
R44	Experiences Arg1:T38 Arg2:T31	
R45	Has_Dose_or_Strength Arg1:T17 Arg2:T41	
R46	Has_Drug_Form Arg1:T17 Arg2:T44	
R47	Has_Dose_or_Strength Arg1:T17 Arg2:T43	
R48	Has_Dose_or_Strength Arg1:T17 Arg2:T42	
R49	Experiences Arg1:T56 Arg2:T17	
R50	Has_Duration_or_Interval Arg1:T17 Arg2:T45	
R51	Used_for Arg1:T18 Arg2:T55	
T62	Observation 789 808	elevación del c-HDL
#52	AnnotatorNotes T62	C2938903; HDL cholesterol increased; Finding
R52	Causes Arg1:T18 Arg2:T62	
T63	Observation 740 760;770 776	caída en los valores del CT
R53	Causes Arg1:T18 Arg2:T63	
T64	Observation 740 760;770 773;780 784	caída en los valores del AGNE
#53	AnnotatorNotes T64	C1695780; Free fatty acids decreased; Finding
R54	Causes Arg1:T18 Arg2:T64	
R58	Before Arg1:T12 Arg2:T32	
R59	Before Arg1:T8 Arg2:T17	
R64	Experiences Arg1:T49 Arg2:T25	
R65	Experiences Arg1:T49 Arg2:T13	
R66	Experiences Arg1:T49 Arg2:T58	
R67	Experiences Arg1:T49 Arg2:T23	
T66	CONC 203 208	dosis
#54	AnnotatorNotes T66	C0178602; Dosage; Quantitative Concept
T67	Quantifier_or_Qualifier 209 217	efectiva
#55	AnnotatorNotes T67	C1704419; Effective; Qualitative Concept 
R68	Has_Quantifier_or_Qualifier Arg1:T66 Arg2:T67	
T68	Observation 1 7	Efecto
#56	AnnotatorNotes T68	C1518681; Outcome of Therapy; Finding (?)
R14	Causes Arg1:T1 Arg2:T68	
#57	AnnotatorNotes T63	C0860921; Cholesterol total decreased; Finding
A3	Experiencer T49 Patient
A4	Experiencer T37 Patient
A5	Experiencer T38 Patient
A6	Experiencer T39 Patient
A7	Experiencer T56 Patient
R13	Has_Result_or_Value Arg1:T21 Arg2:T62	
R15	Has_Result_or_Value Arg1:T20 Arg2:T64	
R16	Has_Result_or_Value Arg1:T19 Arg2:T63	
